PuSH - Publikationsserver des Helmholtz Zentrums München

Tollot-Wegner, M.* ; Jessen, M.* ; Kim, K.* ; Sanz-Moreno, A. ; Spielmann, N. ; Gailus-Durner, V. ; Fuchs, H. ; Hrabě de Angelis, M. ; von Eyss, B.*

TRPS1 maintains luminal progenitors in the mammary gland by repressing SRF/MRTF activity.

Breast Cancer Res. 26:74 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The transcription factor TRPS1 is a context-dependent oncogene in breast cancer. In the mammary gland, TRPS1 activity is restricted to the luminal population and is critical during puberty and pregnancy. Its function in the resting state remains however unclear. To evaluate whether it could be a target for cancer therapy, we investigated TRPS1 function in the healthy adult mammary gland using a conditional ubiquitous depletion mouse model where long-term depletion does not affect fitness. Using transcriptomic approaches, flow cytometry and functional assays, we show that TRPS1 activity is essential to maintain a functional luminal progenitor compartment. This requires the repression of both YAP/TAZ and SRF/MRTF activities. TRPS1 represses SRF/MRTF activity indirectly by modulating RhoA activity. Our work uncovers a hitherto undisclosed function of TRPS1 in luminal progenitors intrinsically linked to mechanotransduction in the mammary gland. It may also provide new insights into the oncogenic functions of TRPS1 as luminal progenitors are likely the cells of origin of many breast cancers.
Impact Factor
Scopus SNIP
Altmetric
6.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Breast Cancer ; Luminal Progenitor ; Mammary Gland Homeostasis ; Srf ; Trps1 ; Yap/taz; Breast-cancer; Differentiation; Growth; Cells; Regulator; Complex; Origin; Target; Gata-3; Brca1
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 1465-5411
e-ISSN 1465-542X
Quellenangaben Band: 26, Heft: 1, Seiten: , Artikelnummer: 74 Supplement: ,
Verlag BioMed Central
Verlagsort Campus, 4 Crinan St, London N1 9xw, England
Begutachtungsstatus Peer reviewed
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500692-001
G-500600-001
Förderungen State of Thuringia
Federal Government of Germany
German Cancer Aid (Deutsche Krebshilfe)
DFG
BMBF
Projekt DEAL
Scopus ID 85192062593
PubMed ID 38702730
Erfassungsdatum 2024-05-21